Del Re M - Search Results

1

Understanding EGFR heterogeneity in lung cancer.

Passaro A, Malapelle U, Del Re M, Attili I, Russo A, Guerini-Rocco E, Fumagalli C, Pisapia P, Pepe F, De Luca C, Cucchiara F, Troncone G, Danesi R, Spaggiari L, De Marinis F, Rolfo C. Passaro A, et al. Among authors: del re m. ESMO Open. 2020 Oct;5(5):e000919. doi: 10.1136/esmoopen-2020-000919. ESMO Open. 2020. PMID: 33067323 Free PMC article. Review.

2

Pharmacokinetic and pharmacogenetic predictive markers of irinotecan activity and toxicity.

Di Paolo A, Bocci G, Polillo M, Del Re M, Di Desidero T, Lastella M, Danesi R. Di Paolo A, et al. Among authors: del re m. Curr Drug Metab. 2011 Dec;12(10):932-43. doi: 10.2174/138920011798062283. Curr Drug Metab. 2011. PMID: 21787264 Review.

3

Pharmacogenetics of anti-estrogen treatment of breast cancer.

Del Re M, Michelucci A, Simi P, Danesi R. Del Re M, et al. Cancer Treat Rev. 2012 Aug;38(5):442-50. doi: 10.1016/j.ctrv.2011.08.003. Epub 2011 Sep 13. Cancer Treat Rev. 2012. PMID: 21917382 Review.

4

Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine?

Del Re M, Di Paolo A, van Schaik RH, Bocci G, Simi P, Falcone A, Danesi R. Del Re M, et al. EPMA J. 2010 Sep;1(3):495-502. doi: 10.1007/s13167-010-0041-2. Epub 2010 Jul 25. EPMA J. 2010. PMID: 23199091 Free PMC article.

5

Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature.

Tomisti L, Del Re M, Bartalena L, Tanda ML, Pucci A, Pambianco F, Danesi R, Braverman LE, Martino E, Bogazzi F. Tomisti L, et al. Among authors: del re m. Endocr Pract. 2013 Nov-Dec;19(6):1043-9. doi: 10.4158/EP13093.RA. Endocr Pract. 2013. PMID: 23807523 Review.

6

Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer.

Del Re M, Vasile E, Falcone A, Danesi R, Petrini I. Del Re M, et al. Expert Rev Mol Diagn. 2014 May;14(4):453-68. doi: 10.1586/14737159.2014.908120. Epub 2014 Apr 11. Expert Rev Mol Diagn. 2014. PMID: 24725257 Review.

7

Genetic variation: effect on prostate cancer.

Sissung TM, Price DK, Del Re M, Ley AM, Giovannetti E, Figg WD, Danesi R. Sissung TM, et al. Among authors: del re m. Biochim Biophys Acta. 2014 Dec;1846(2):446-56. doi: 10.1016/j.bbcan.2014.08.007. Epub 2014 Sep 6. Biochim Biophys Acta. 2014. PMID: 25199985 Free PMC article. Review.

8

Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight.

Aprile G, Ongaro E, Del Re M, Lutrino SE, Bonotto M, Ferrari L, Rihawi K, Cardellino GG, Pella N, Danesi R, Fasola G. Aprile G, et al. Among authors: del re m. Crit Rev Oncol Hematol. 2015 Aug;95(2):165-78. doi: 10.1016/j.critrevonc.2015.02.009. Epub 2015 Mar 5. Crit Rev Oncol Hematol. 2015. PMID: 25800976 Review.

9

Methods: for studying pharmacogenetic profiles of combination chemotherapeutic drugs.

Di Paolo A, Polillo M, Lastella M, Bocci G, Del Re M, Danesi R. Di Paolo A, et al. Among authors: del re m. Expert Opin Drug Metab Toxicol. 2015;11(8):1253-67. doi: 10.1517/17425255.2015.1053460. Epub 2015 Jun 3. Expert Opin Drug Metab Toxicol. 2015. PMID: 26037261 Review.

10

Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in patients.

Del Re M, Michelucci A, Di Leo A, Cantore M, Bordonaro R, Simi P, Danesi R. Del Re M, et al. EPMA J. 2015 Sep 2;6(1):17. doi: 10.1186/s13167-015-0039-x. eCollection 2015. EPMA J. 2015. PMID: 26330892 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page